Stocks
Cancel

AstraZeneca Pharma India Ltd.

24 Sep, 2020, 03:55 PM IST
24 Sep, 2020, 04:00 PM IST
NSE
BSE
4214.10-101.35-2.35%
Today's Trend
Low
4200.00
High
4350.00
Volume
52,266
Open
4238.00
Prev Close
4315.45
4213.35-104.25-2.41%
Today's Trend
Low
4200.00
High
4349.25
Volume
7,079
Open
4201.00
Prev Close
4317.60
Open trading A/c + Watchlist
+ Portfolio

Technical Chart

  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
Bid
Offer

Mkt Cap (₹ Cr.)

10535.25
10533.38

Face Value (₹)

2.00
2.00
P/E (x)
151.96
151.93
EPS-TTM(₹)
27.73
27.73
P/B (x)
16.41
16.41
BV/Sh(x)
145.78
145.78
Div. Yield(%)
0.02
0.02
52Wk L/H
1885.00
4970.00
1888.00
4970.00

AstraZeneca Pharma India Ltd.
News & Recos

  • Stock market news: AstraZeneca Pharma shares tank nearly 6%
  • Announcement under Regulation 30 (LODR)-Dividend Updates
  • Astrazeneca Pharma India Limited Receives Import And Market Permission In Form CT-20 (Marketing Authorization) From Drugs Controller General Of India (DCGI) For Olaparib Film - Coated Tablets 100 Mg And 150 Mg For Additional Indication
  • Announcement under Regulation 30 (LODR)-Newspaper Publication
  • Announcement under Regulation 30 (LODR)-Change in Directorate
MORE FROM NEWS & RECOS

AstraZeneca Pharma India Ltd. Share Price Updates

AstraZeneca Pharma India Ltd. share price
down -2.35%
down -2.41%
from its previous close of Rs
4315.45
4317.60
. AstraZeneca Pharma India Ltd. stock last traded price is
4214.10
4213.35
AstraZeneca Pharma India Ltd. Share Price
Value
Today/Current/Last
4214.10
4213.35
Previous Day
4315.45
4317.60

AstraZeneca Pharma India Ltd. Earnings
(Figures in Rs. Cr.)

Sales

Other Income

Operating Profit

Other Operating
Income

EBITDA

Interest

Depreciation

Tax

Net Profit

EPS (₹)

Jun 2020
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
193.58
-0.68
-5.37
0.13
1064.27
0.00
0.00
0.00
0.00
0.00
28.57
93.22
-19.66
-0.11
774.92
2.65
-21.57
-11.41
0.00
57.79
31.22
71.88
-19.02
-0.11
774.92
0.27
2.82
-7.28
0.00
4.45
4.56
0.38
-1.42
0.01
27.14
7.75
105.34
-36.03
-0.36
62.15
18.63
94.55
-13.39
-0.93
180.35
7.45
94.52
-13.47
-0.88
84.87
AstraZeneca Pharma India Ltd ResultsAstraZeneca Pharma I Q1 ResultsAstraZeneca Pharma I Q2 ResultsAstraZeneca Pharma I Q3 ResultsAstraZeneca Pharma I Q4 Results

AstraZeneca Pharma India Ltd. Stock Performance

Period:
Company
LTP
%Change
Trend
4214.10
-2.35
1545.80
-2.66
8387.00
-1.13
4881.00
-0.63
15982.90
-0.03
4809.00
-3.08

AstraZeneca Pharma India Ltd. Financial Performance

LTP
(₹)
Market Cap
(Cr.)
Price to
Book
Price to
Earnings
PAT
Margins
RoE%
RoA%
Debt to
Equity
Avg. Cost
of Funds%
Current
Ratio
4214.10
10574.25
16.41
152.52
8.6800
30.3600
10.2200
0.00
0.6800
1.66
4809.00
7972.35
3.32
47.09
98.7900
9.6800
47.6600
0.00
0.0000
7.83
8387.00
19312.56
6.61
43.34
13.4800
25.9500
12.7600
0.00
6.2200
3.03
4881.00
22414.56
1.55
43.04
40.8500
22.9300
27.2100
0.00
4.8400
5.04
1545.80
26377.37
11.59
291.49
2.8900
30.9500
2.9700
0.00
22.4300
1.73
15982.90
33998.35
13.51
51.80
14.4800
30.5400
16.7100
0.00
5.6700
3.60

AstraZeneca Pharma India Ltd. Financial Comparison with peers

Management Efficiency

Return On Equity (%)

Return On Assets (%)

Return On Capital Employed (%)

Fixed Assets Turnover (x)

Profitability & Growth

Gross Profit Margin (%)

Operating Profit Margin (%)

Net Profit Margin (%)

Financial Strength
Liquidity

Quick Ratio (x)

Current Ratio (x)

Cash Ratio (x)

Solvency

Debt Equity Ratio (x)

Coverage Ratios

Cash Flows to Long Term Debt (x)

AstraZeneca Pharma India Ltd.
Peer
Average
Peer Range
Trend
19.81
12.58
0.00
28.03
10.22
8.50
-1.90
21.61
19.19
11.77
-13.76
33.12
2.50
1.36
0.20
2.50
12.27
12.79
-5.25
23.26
14.51
15.44
3.25
26.61
8.68
9.87
-3.59
23.66
1.26
2.71
0.14
7.96
1.79
3.23
0.37
8.87
0.74
1.06
0.01
2.42
0.00
0.41
0.00
3.21
0.00
5.54
0.00
37.15

AstraZeneca Pharma India Ltd. Share Holding

  • Categories
    No. Of Shares
    %
  • NoOfShares
    25,000,000
    100.00
  • Promoters
    0
    0.00
  • ForeignInstitutions
    297,123
    1.19
  • NBanksMutualFunds
    801,435
    3.21
  • Others
    978,894
    3.92
  • GeneralPublic
    4,125,854
    16.50
  • FinancialInstitutions
    46,694
    0.19
  • ForeignPromoter
    18,750,000
    75.00

Mutual Fund Ownership

Fund Name
ICICI Pru Long Term Equity (Tax Saving) Direct-G
Nippon India Small Cap Direct-G
ICICI Pru Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-G
Sundaram Small Cap Direct-G
Tata India Pharma & HealthCare Direct-G
Category
Rating
No. of shares
%Change in Shares
(MOM basis)
% of AUM
Amount Invested
(in ₹ Cr)
Equity: ELSS
348514
0.00%
1.89%
123.71
Equity: Small Cap
275000
-4.53%
1.05%
97.62
Equity: Sectoral-Pharma
46715
0.00%
0.9%
16.58
Equity: Small Cap
30884
0.00%
1.05%
10.96
Equity: Sectoral-Pharma
5000
0.00%
0.6%
1.77

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About AstraZeneca Pharma India Ltd.

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 10535.25 Crore) operating in Pharmaceuticals sector.

AstraZeneca Pharma India Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 801.26 Crore to Sales Value (96.32 % of Total Sales), Sale of services which contributed Rs 30.51 Crore to Sales Value (3.66 % of Total Sales), Scrap which contributed Rs .04 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2020.

For the quarter ended 30-06-2020, the company has reported a Standalone sales of Rs 193.58 Crore, down -.68 % from last quarter Sales of Rs 194.90 Crore and down -5.37 % from last year same quarter Sales of Rs 204.56 Crore Company has reported net profit after tax of Rs 18.63 Crore in latest quarter.

The company’s top management includes Mr.Gagandeep Singh Bedi, Mr.Ian John Parish, Mr.Narayan K Seshadri, Mr.Rajesh Marwaha, Ms.Kimsuka Narsimhan, Ms.Revathy Ashok, Ms.Weiying Sarah Wang. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors As on 30-06-2020, the company has a total of 25,000,000 shares outstanding.

Loading data...
More on:
Prices| Financials | Company Info | Reports | News | Competitors
Business News › Markets › Stocks › Stock Price Quotes
Text Size:AAA

Popular Categories

Hot on Web

In Case you missed it

More from our network

Download ET APP


Follow us on



Become a member

Terms of Use & Grievance Redressal Policy
Privacy Policy|Feedback

Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service

LOGIN & CLAIM

50 TIMESPOINTS

Markets Data
GetET MarketsAPP
Market Data
3 BEST MFsEq. GainersNew 52W HighMost ActiveMACD : ScreenerTop ELSSDownload ET Markets APP
Markets Data
GetET MarketsAPP
Market Data
3 BEST MFsEq. GainersNew 52W HighMost ActiveMACD : ScreenerTop ELSSDownload ET Markets APP